You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pirfenidone

Showing 26 - 50 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Drug Interaction Trial in Miami (Pirfenidone 267 mg Oral Tablet, Nintedanib 150 mg Oral Capsule, BLD-0409 750 mg Oral

Completed
  • Drug Drug Interaction
  • Pirfenidone 267 mg Oral Tablet
  • +2 more
  • Miami, Florida
    Advanced Pharma
Apr 14, 2022

Silicosis, Progressive Massive Fibrosis, Complicated Silicosis Trial in Cadiz (Pirfenidone Oral Tablet)

Recruiting
  • Silicosis
  • +2 more
  • Pirfenidone Oral Tablet
  • Cadiz, Spain
    Antonio León Jiménez
Dec 27, 2021

Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)

Recruiting
  • Fibrotic Pulmonary Sequelae Post-COVID19 Infection
  • Pirfenidone
  • Placebo
  • Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Dec 29, 2021

Idiopathic Pulmonary Fibrosis Trial in Seongnam-si (DWN12088, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Seongnam-si, Korea, Republic of
    Cha Unitersity Bundang Medical Center
Sep 22, 2021

HF: Circulating Biomarkers of Fibrosis and Cardiovascular

Completed
  • Heart Failure With Preserved Ejection Fraction
  • Pirfenidone
  • Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Apr 21, 2023

Safety of Nintedanib in Real World in China

Not yet recruiting
  • Pulmonary Fibrosis
  • Beijing, China
    China-Japan Friendship Hospital
Jan 26, 2023

Based on Medical Records That Looks at Characteristics of

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • Plymouth, Pennsylvania
    Plymouth Meeting
Nov 12, 2021

Progressive Idiopathic Pulmonary Fibrosis Trial in France (pirfenidone and nintedanib, pirfenidone or nintedanib)

Recruiting
  • Progressive Idiopathic Pulmonary Fibrosis
  • pirfenidone and nintedanib
  • pirfenidone or nintedanib
  • Angers, France
  • +15 more
Jan 20, 2022

Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • EGCG + Nintedanib
  • +2 more
  • San Francisco, California
    UCSF Parnassus
Apr 25, 2022

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, DMARDs)

Recruiting
  • Pirfenidone
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital
Jun 9, 2021

Idiopathic Pulmonary Fibrosis Trial (Cudetaxestat (BLD-0409), Control: Matching Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Cudetaxestat (BLD-0409)
  • Control: Matching Placebo
  • (no location specified)
May 12, 2022

Interstitial Lung Disease Trial in Denver (Pirfenidone, Placebo controlled)

Completed
  • Interstitial Lung Disease
  • Pirfenidone
  • Placebo controlled
  • Denver, Colorado
    National Jewish Health
May 13, 2021

Pulmonary Fibrosis Trial in Paris (Pirfenidone)

Completed
  • Pulmonary Fibrosis
  • Pirfenidone
  • Paris, France
    Cochin Hospital
Apr 30, 2021

Rheumatoid Arthritis Interstitial Lung Disease Trial in Worldwide (Pirfenidone, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis Interstitial Lung Disease
  • Pirfenidone
  • Placebo
  • Birmingham, Alabama
  • +32 more
Jul 20, 2022

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Completed
  • Idiopathic Pulmonary Fibrosis
  • Pulmonary Fibrosis
    • Leuven, BE, Belgium
      University Hospitals Leuven
    Mar 15, 2021

    Hypersensitivity Pneumonitis Trial in Zagazig (Oral pirfenidone, Standard care)

    Completed
    • Hypersensitivity Pneumonitis
    • Oral pirfenidone
    • Standard care
    • Zagazig, Egypt
      Eman Shebl
    Dec 15, 2020

    Idiopathic Pulmonary Fibrosis Trial in Beijing (HEC585, Pirfenidone, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Beijing, Beijing, China
      China-Japan Friendship Hospital
    Sep 18, 2021

    Idiopathic Pulmonary Fibrosis Trial in Russian Federation (Pirfenidone)

    Completed
    Has Results
    • Idiopathic Pulmonary Fibrosis
    • Pirfenidone
    • Barnaul, Altaj, Russian Federation
    • +10 more
    Nov 18, 2020

    Cardiac Failure Trial in Manchester (Pirfenidone, Placebo)

    Completed
    • Cardiac Failure
    • Pirfenidone
    • Placebo
    • Manchester, Greater Manchester, United Kingdom
      Manchester University NHS Foundation Trust
    Jul 1, 2020

    Participants With IPF Under Pirfenidone Treatment

    Completed
    • Idiopathic Pulmonary Fibrosis
    • Pirfenidone
    • Athens, Greece
    • +6 more
    Aug 20, 2020

    Idiopathic Pulmonary Fibrosis (IPF) Trial in Salt Lake City (BMS-986278, Pirfenidone)

    Completed
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Salt Lake City, Utah
      PRA Health Sciences - Salt Lake
    May 14, 2020

    Idiopathic Pulmonary Fibrosis Trial in United States (Placebo, Pirfenidone, Deupirfenidone)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +39 more
    Dec 20, 2022

    Pulmonary Disease Trial in Worldwide (MUFA Diet, SFA Diet)

    Completed
    • Pulmonary Disease
    • MUFA Diet
    • SFA Diet
    • Essen, Germany
    • +5 more
    Jul 15, 2020

    Novel Coronavirus Pneumonia, Pneumonia, Pirfenidone Trial in Wuhan (pirfenidone)

    Unknown status
    • Novel Coronavirus Pneumonia
    • +2 more
    • pirfenidone
    • Wuhan, Hubei, China
      Tongji hospital affiliated to huazhong university of science and
    Feb 21, 2020

    (NIS) Collecting Experiences For IPF in Taiwan

    Completed
    Has Results
    • Pulmonary Fibrosis
    • Changhua, Taiwan
    • +9 more
    Mar 19, 2021